SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shasha Qian, Wei Guo, Jiannan Xing, Qianqian Qin, Zhengwei Ding, Fangfang Chen, Zhihang Peng, Lu Wang, Diversity of HIV/AIDS epidemic in China, AIDS, 2014, 28, 12, 1805

    CrossRef

  2. 2
    Jo Brocato, Dennis G. Fisher, Grace L. Reynolds, Mike A. Janson, Drug Treatment Utilization Among Illicit Drug Users Receiving HIV Prevention Services in Los Angeles County, Journal of HIV/AIDS & Social Services, 2014, 13, 2, 125

    CrossRef

  3. 3
    George E. Woody, Douglas Bruce, P. Todd Korthuis, Sumedha Chhatre, Sabrina Poole, Maureen Hillhouse, Petra Jacobs, James Sorensen, Andrew J. Saxon, David Metzger, Walter Ling, HIV Risk Reduction With Buprenorphine–Naloxone or Methadone, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014, 66, 3, 288

    CrossRef

  4. 4
    Jonathan Feelemyer, Don Des Jarlais, Kamyar Arasteh, Abu S. Abdul-Quader, Holly Hagan, Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review, Addiction, 2014, 109, 1
  5. 5
    Jack DeHovitz, Anneli Uuskula, Nabila El-Bassel, The HIV Epidemic in Eastern Europe and Central Asia, Current HIV/AIDS Reports, 2014, 11, 2, 168

    CrossRef

  6. 6
    August F. Holtyn, Mikhail N. Koffarnus, Anthony DeFulio, Sigurdur O. Sigurdsson, Eric C. Strain, Robert P. Schwartz, Jeannie-Marie S. Leoutsakos, Kenneth Silverman, The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: A randomized controlled trial, Preventive Medicine, 2014,

    CrossRef

  7. 7
    Zunyou Wu, Cynthia X. Shi, Roger Detels, Addressing Injecting Drug Use in Asia and Eastern Europe, Current HIV/AIDS Reports, 2013, 10, 2, 187

    CrossRef

  8. 8
    Jeanette M. Tetrault, Michael J. Kozal, Jennifer Chiarella, Lynn E. Sullivan, An T. Dinh, David A. Fiellin, Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment, Journal of Addiction Medicine, 2013, 7, 2, 102

    CrossRef

  9. 9
    Jeannia J. Fu, Nickolas D. Zaller, Michael A. Yokell, Alexander R. Bazazi, Josiah D. Rich, Forced withdrawal from methadone maintenance therapy in criminal justice settings: A critical treatment barrier in the United States, Journal of Substance Abuse Treatment, 2013, 44, 5, 502

    CrossRef

  10. 10
    Jianhua Li, Changhe Wang, Jennifer M McGoogan, Keming Rou, Marc Bulterys, Zunyou Wu, Human resource development and capacity-building during China’s rapid scale-up of methadone maintenance treatment services, Bulletin of the World Health Organization, 2013, 91, 2, 130

    CrossRef

  11. 11
    Yan Zhao, Cynthia X Shi, Jennifer M McGoogan, Keming Rou, Fujie Zhang, Zunyou Wu, Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China, Bulletin of the World Health Organization, 2013, 91, 2, 93

    CrossRef

  12. 12
    Jeanette M. Tetrault, Brent A. Moore, Declan T. Barry, Patrick G. O'Connor, Richard Schottenfeld, David A. Fiellin, Lynn E. Fiellin, Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients, Journal of Substance Abuse Treatment, 2012, 43, 4, 433

    CrossRef

  13. 13
    Min Zhao, Walter Ling, HIV/AIDS and Drug Use in China—Interactions, Impacts, and Issues, Substance Use & Misuse, 2012, 47, 8-9, 1015

    CrossRef

  14. 14
    Sharon M. Kelly, Robert P. Schwartz, Kevin E. OʼGrady, Devang Gandhi, Jerome H. Jaffe, Impact of Methadone With Versus Without Drug Abuse Counseling on HIV Risk, Journal of Addiction Medicine, 2012, 6, 2, 145

    CrossRef

  15. 15
    Ronald O. Valdiserri, Commentary: Thirty Years of AIDS in America: A Story of Infinite Hope, AIDS Education and Prevention, 2011, 23, 6, 479

    CrossRef

  16. 16
    Jeffrey D. Baxter, Robin E. Clark, Mihail Samnaliev, Gary Y. Leung, Lobat Hashemi, Factors associated with Medicaid patients' access to buprenorphine treatment, Journal of Substance Abuse Treatment, 2011, 41, 1, 88

    CrossRef

  17. 17
    Lin Zhao, William L. Holzemer, Mallory Johnson, Jacqueline P. Tulsky, Carol Dawson Rose, HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users, AIDS Care, 2011, 1

    CrossRef

  18. 18
    Alexis N. Martinez, Ricky N. Bluthenthal, Neil M. Flynn, Rachel L. Anderson, Alex H. Kral, HIV Risks and Seroprevalence Among Mexican American Injection Drug Users in California, AIDS and Behavior, 2011, 15, 1, 95

    CrossRef

  19. 19
    Qing Ma, Barry S Zingman, Amneris E Luque, Margaret A Fischl, Barbara M Gripshover, Charles S Venuto, Robin DiFrancesco, Alan Forrest, Gene D Morse, Therapeutic Drug Monitoring of Protease Inhibitors and Efavirenz in HIV-Infected Individuals With Active Substance-Related Disorders, Therapeutic Drug Monitoring, 2011, 33, 3, 309

    CrossRef

  20. 20
    Matthew J. Mimiaga, Steven A. Safren, Sergiy Dvoryak, Sari L. Reisner, Richard Needle, George Woody, “We fear the police, and the police fear us”: structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine, AIDS Care, 2010, 22, 11, 1305

    CrossRef

  21. 21
    Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne Manubay, Leslie Amass, Ziva D. Cooper, Phillip Saccone, Herbert D. Kleber, Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers, Addiction, 2010, 105, 4
  22. 22
    David S Metzger, George E Woody, Charles P OʼBrien, Drug Treatment as HIV Prevention: A Research Update, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010, 55, S32

    CrossRef

  23. 23
    David S. Metzger, Yan Zhang, Drug Treatment as HIV Prevention: Expanding Treatment Options, Current HIV/AIDS Reports, 2010, 7, 4, 220

    CrossRef

  24. 24
    Kent Ranson, Tyler J. Law, Sara Bennett, Establishing health systems financing research priorities in developing countries using a participatory methodology, Social Science & Medicine, 2010, 70, 12, 1933

    CrossRef

  25. 25
    Amy Nunn, Alexandra Cornwall, Jeannia Fu, Lauri Bazerman, Helen Loewenthal, Curt Beckwith, Linking HIV-positive Jail Inmates to Treatment, Care, and Social Services After Release: Results from a Qualitative Assessment of the COMPASS Program, Journal of Urban Health, 2010, 87, 6, 954

    CrossRef

  26. 26
    Jennifer Syvertsen, Robin A. Pollini, Remedios Lozada, Alicia Vera, Gudelia Rangel, Steffanie A. Strathdee, Managing la malilla: Exploring drug treatment experiences among injection drug users in Tijuana, Mexico, and their implications for drug law reform, International Journal of Drug Policy, 2010, 21, 6, 459

    CrossRef

  27. 27
    Curt G Beckwith, Nickolas D Zaller, Jeannia J Fu, Brian T Montague, Josiah D Rich, Opportunities to Diagnose, Treat, and Prevent HIV in the Criminal Justice System, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010, 55, S49

    CrossRef

  28. 28
    Louisa Degenhardt, Bradley Mathers, Peter Vickerman, Tim Rhodes, Carl Latkin, Matt Hickman, Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed, The Lancet, 2010, 376, 9737, 285

    CrossRef

  29. 29
    Alex Wodak, Lisa Maher, The effectiveness of harm reduction in preventing HIV among injecting drug users, New South Wales Public Health Bulletin, 2010, 21, 4, 69

    CrossRef

  30. 30
    Chris Beyrer, Zeenat Patel, Julie A. Stachowiak, Farida K. Tishkova, Mark A. Stibich, Lindsay M. Eyzaguirre, Jean K. Carr, Vladimir Mogilnii, Alena Peryshkina, Alisher Latypov, Steffanie A. Strathdee, Characterization of the Emerging HIV Type 1 and HCV Epidemics among Injecting Drug Users in Dushanbe, Tajikistan, AIDS Research and Human Retroviruses, 2009, 25, 9, 853

    CrossRef

  31. 31
    Albert Stuart Reece, Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine, Journal of Substance Abuse Treatment, 2009, 37, 3, 256

    CrossRef

  32. 32
    Declan T. Barry, Kevin S. Irwin, Emlyn S. Jones, William C. Becker, Jeanette M. Tetrault, Lynn E. Sullivan, Helena Hansen, Patrick G. O’Connor, Richard S. Schottenfeld, David A. Fiellin, Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study, Journal of General Internal Medicine, 2009, 24, 2, 218

    CrossRef

  33. 33
    Sukhwinder S Lakhman, Qing Ma, Gene D Morse, Pharmacogenomics ofCYP3A: considerations for HIV treatment, Pharmacogenomics, 2009, 10, 8, 1323

    CrossRef

  34. 34
    Crystal M. Fuller, Chandra Ford, Abby Rudolph, HIV Prevention, 2009,

    CrossRef

  35. 35
    Richard S Schottenfeld, Marek C Chawarski, Mahmud Mazlan, Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial, The Lancet, 2008, 371, 9631, 2192

    CrossRef

  36. 36
    Jeffrey H. Samet, Evgeny M. Krupitsky, Debbie M. Cheng, Anita Raj, Valentina Y. Egorova, Suzette Levenson, Seville Meli, Carly Bridden, Elena V. Verbitskaya, Mary L. Kamb, Edwin E. Zvartau, Mitigating risky sexual behaviors among Russian narcology hospital patients: the PREVENT (Partnership to Reduce the Epidemic Via Engagement in Narcology Treatment) randomized controlled trial, Addiction, 2008, 103, 9
  37. 37
    Robert J. Roose, Hillary V. Kunins, Nancy L. Sohler, Rashiah T. Elam, Chinazo O. Cunningham, Nurse practitioner and physician assistant interest in prescribing buprenorphine, Journal of Substance Abuse Treatment, 2008, 34, 4, 456

    CrossRef

  38. 38
    Michael Soyka, Christina Zingg, Gabriele Koller, Heinrich Kuefner, Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study, The International Journal of Neuropsychopharmacology, 2008, 11, 05

    CrossRef

  39. 39
    Philip Todd Korthuis, Joshua S. Josephs, John A. Fleishman, James Hellinger, Seth Himelhoch, Geetanjali Chander, Elizabeth B. Morse, Kelly A. Gebo, Substance abuse treatment in human immunodeficiency virus: The role of patient–provider discussions, Journal of Substance Abuse Treatment, 2008, 35, 3, 294

    CrossRef

  40. 40
    Eugenia Oviedo-Joekes, Bohdan Nosyk, Suzanne Brissette, Jill Chettiar, Pascal Schneeberger, David C. Marsh, Michael Krausz, Aslam Anis, Martin T. Schechter, The North American Opiate Medication Initiative (NAOMI): Profile of Participants in North America’s First Trial of Heroin-Assisted Treatment, Journal of Urban Health, 2008, 85, 6, 812

    CrossRef

  41. 41
    Richard S Garfein, Elizabeth T Golub, Alan E Greenberg, Holly Hagan, Debra L Hanson, Sharon M Hudson, Farzana Kapadia, Mary H Latka, Lawrence J Ouellet, David W Purcell, Steffanie A Strathdee, Hanne Thiede, A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users, AIDS, 2007, 21, 14, 1923

    CrossRef

  42. 42
    Robert P. Schwartz, Jerome H. Jaffe, David A. Highfield, Jason M. Callaman, Kevin E. O’Grady, A randomized controlled trial of interim methadone maintenance: 10-Month follow-up, Drug and Alcohol Dependence, 2007, 86, 1, 30

    CrossRef

  43. 43
    Wen-yuan Yin, Zun-you Wu, Challenges and opportunities: the expanded government-led HIV/AIDS programs in China, Virologica Sinica, 2007, 22, 6, 493

    CrossRef

  44. 44
    Zunyou Wu, Sheena G Sullivan, Yu Wang, Mary Jane Rotheram-Borus, Roger Detels, Evolution of China's response to HIV/AIDS, The Lancet, 2007, 369, 9562, 679

    CrossRef

  45. 45
    Laurie Sylla, R. Douglas Bruce, Adeeba Kamarulzaman, Frederick L. Altice, Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services, International Journal of Drug Policy, 2007, 18, 4, 306

    CrossRef

  46. 46
    Richard S. Garfein, Andrea Swartzendruber, Lawrence J. Ouellet, Farzana Kapadia, Sharon M. Hudson, Hanne Thiede, Steffanie A. Strathdee, Ian T. Williams, Susan L. Bailey, Holly Hagan, Elizabeth T. Golub, Peter Kerndt, Debra L. Hanson, Mary H. Latka, Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT), Drug and Alcohol Dependence, 2007, 91, S4

    CrossRef

  47. 47
    Jason M White, Olga V Lopatko, Opioid maintenance: a comparative review of pharmacological strategies, Expert Opinion on Pharmacotherapy, 2007, 8, 1, 1

    CrossRef

  48. 48
    Sanjay Basu, R. Douglas Bruce, Declan T. Barry, Frederick L. Altice, Pharmacological pain control for human immunodeficiency virus–infected adults with a history of drug dependence, Journal of Substance Abuse Treatment, 2007, 32, 4, 399

    CrossRef

  49. 49
    M. P. Carrieri, L. Amass, G. M. Lucas, D. Vlahov, A. Wodak, G. E. Woody, Buprenorphine Use: The International Experience, Clinical Infectious Diseases, 2006, 43, Supplement 4, S197

    CrossRef

  50. 50
    Erin L. Winstanley, Steven W. Gust, Steffanie A. Strathdee, Drug abuse and HIV/AIDS: international research lessons and imperatives, Drug and Alcohol Dependence, 2006, 82, S1

    CrossRef

  51. 51
    Steffanie A. Strathdee, Erin P. Ricketts, Steven Huettner, Lee Cornelius, David Bishai, Jennifer R. Havens, Peter Beilenson, Charles Rapp, Jacqueline J. Lloyd, Carl A. Latkin, Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial, Drug and Alcohol Dependence, 2006, 83, 3, 225

    CrossRef

  52. 52
    David C. Lott, Eric C. Strain, Robert K. Brooner, George E. Bigelow, Rolley E. Johnson, HIV risk behaviors during pharmacologic treatment for opioid dependence: A comparison of levomethadyl acetate hydrochloride, buprenorphine, and methadone, Journal of Substance Abuse Treatment, 2006, 31, 2, 187

    CrossRef

  53. 53
    L. E. Sullivan, R. D. Bruce, D. Haltiwanger, G. M. Lucas, L. Eldred, R. Finkelstein, D. A. Fiellin, Initial Strategies for Integrating Buprenorphine into HIV Care Settings in the United States, Clinical Infectious Diseases, 2006, 43, Supplement 4, S191

    CrossRef

  54. 54
    D. A. Fiellin, G. H. Friedland, M. N. Gourevitch, Opioid Dependence: Rationale for and Efficacy of Existing and New Treatments, Clinical Infectious Diseases, 2006, 43, Supplement 4, S173

    CrossRef

  55. 55
    Valérie Andresz, Nicolas Marcantoni, Florence Binder, Michel Velten, Martine Alt, Jean-Christophe Weber, Dominique Stephan, Puffy hand syndrome due to drug addiction: a case–control study of the pathogenesis, Addiction, 2006, 101, 9
  56. 56
    F. González-Saiz, Aspectos farmacoeconómicos de los tratamientos con buprenorfina, Trastornos Adictivos, 2005, 7, 1, 31

    CrossRef

  57. 57
    F. JAVIER ALVAREZ, FRANCISCO GONZÁLEZ-SAIZ, BUPRENORPHINE PRESCRIPTION AND THE INCREASED RELATIVE COST, Addiction, 2005, 100, 9